Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality

Journal of Cerebral Blood Flow and Metabolism

Volumn 35, Issue 7, 2015, Pages 1206-1212

  Da Silva Candal, Andrés ^a   Vieites Prado, Alba ^a   Gutiérrez Fernández, María ^b   Rey, Ramón I ^a   Argibay, Bárbara ^a   Mirelman, David ^c   Sobrino, Tomás ^a   Rodríguez Frutos, Berta ^b   Castillo, José ^a   Campos, Francisco ^a  

^a University Hospital of Santiago de Compostela   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

blood glutamate grabbing; GOT; intracerebral hemorrhage; oxaloacetate; protection

Indexed keywords

ASPARTATE AMINOTRANSFERASE ISOENZYME 1; GLUTAMIC ACID; OXALOACETIC ACID; RECOMBINANT PROTEIN;

ANIMAL; BLOOD; CEREBRAL HEMORRHAGE; COMPLICATION; ENZYME THERAPY; HEMATOMA; HUMAN; MALE; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ASPARTATE AMINOTRANSFERASE, CYTOPLASMIC; CEREBRAL HEMORRHAGE; ENZYME THERAPY; GLUTAMIC ACID; HEMATOMA; HUMANS; MALE; OXALOACETIC ACID; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 84934439273     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.28     Document Type: Article

References (36)

1. Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 2007; 27: 894-908
2. Katsuki H. Exploring neuroprotective drug therapies for intracerebral hemorrhage. J Pharmacol Sci 2010; 114: 366-378
3. Belur PK, Chang JJ, He S, Emanuel BA, Mack WJ. Emerging experimental therapies for intracerebral hemorrhage: targeting mechanisms of secondary brain injury. Neurosurg Focus 2013; 34: E9
4. Qureshi AI, Ali Z, Suri MF, Shuaib A, Baker G, Todd K, et al. Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study. Crit Care Med 2003; 31: 1482-1489
5. Leira R, Castellanos M, Alvarez-Sabin J, Diez-Tejedor E, Davalos A, Castillo J. Headache in cerebral hemorrhage is associated with inflammatory markers and higher residual cavity. Headache 2005; 45: 1236-1243
6. Castillo J, Davalos A, Alvarez-Sabin J, Pumar JM, Leira R, Silva Y, et al. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 2002; 58: 624-629
7. Lee ST, Chu K, Jung KH, Kim J, Kim EH, Kim SJ, et al. Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement. J Cereb Blood Flow Metab 2006; 26: 536-544
8. Montagne A, Hebert M, Jullienne A, Lesept F, Le Behot A, Louessard M, et al. Memantine improves safety of thrombolysis for stroke. Stroke 2012; 43: 2774-2781
9. Sharp F, Liu DZ, Zhan X, Ander BP. Intracerebral hemorrhage injury mechanisms: glutamate neurotoxicity, thrombin, and src. Acta Neurochir Suppl 2008; 105: 43-46
10. Lapchak PA, Araujo DM. Advances in hemorrhagic stroke therapy: conventional and novel approaches. Expert Opin Emerg Drugs 2007; 12: 389-406
11. Sinn DI, Lee ST, Chu K, Jung KH, Song EC, Kim JM, et al. Combined neuroprotective effects of celecoxib and memantine in experimental intracerebral hemorrhage. Neurosci Lett 2007; 411: 238-242
12. Thiex R, Weis J, Krings T, Barreiro S, Yakisikli-Alemi F, Gilsbach JM, et al. Addition of intravenous n-methyl-d-Aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages. J Neurosurg 2007; 106: 314-320
13. Campos F, Sobrino T, Ramos-Cabrer P, Castillo J. Oxaloacetate: a novel neuroprotective for acute ischemic stroke. Int J Biochem Cell Biol 2012; 44: 262-265
14. Teichberg VI, Cohen-Kashi-Malina K, Cooper I, Zlotnik A. Homeostasis of glutamate in brain fluids: an accelerated brain-To-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience 2009; 158: 301-308
15. Campos F, Sobrino T, Ramos-Cabrer P, Argibay B, Agulla J, Perez-Mato M, et al. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J Cereb Blood Flow Metab 2011; 31: 1378-1386
16. Knapp L, Gellert L, Kocsis K, Kis Z, Farkas T, Vecsei L, et al. Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat. Cell Mol Neurobiol 2014; 35: 17-22
17. Perez-Mato M, Ramos-Cabrer P, Sobrino T, Blanco M, Ruban A, Mirelman D, et al. Human recombinant glutamate oxaloacetate transaminase 1 (got1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia. Cell Death Dis 2014; 5: e992
18. Rink C, Gnyawali S, Peterson L, Khanna S. Oxygen-inducible glutamate oxaloacetate transaminase as protective switch transforming neurotoxic glutamate to metabolic fuel during acute ischemic stroke. Antioxid Redox Signal 2011; 14: 1777-1785
19. Teichberg VI. Got to rid the body of excess glutamate. J Cereb Blood Flow Metab 2011; 31: 1376-1377
20. Nagy D, Marosi M, Kis Z, Farkas T, Rakos G, Vecsei L, et al. Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex. Cell Mol Neurobiol 2009; 29: 827-835
21. Boyko M, Gruenbaum SE, Gruenbaum BF, Shapira Y, Zlotnik A. Brain to blood glutamate scavenging as a novel therapeutic modality: a review. J Neural Transm 2014; 121: 971-979
22. Zlotnik A, Sinelnikov I, Gruenbaum BF, Gruenbaum SE, Dubilet M, Dubilet E, et al. Effect of glutamate and blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome and pathohistology of the hippocampus after traumatic brain injury in rats. Anesthesiology 2012; 116: 73-83
23. Boyko M, Melamed I, Gruenbaum BF, Gruenbaum SE, Ohayon S, Leibowitz A, et al. The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage. Neurotherapeutics 2012; 9: 649-657
24. Boyko M, Stepensky D, Gruenbaum BF, Gruenbaum SE, Melamed I, Ohayon S, et al. Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamatepyruvate transaminase and their blood glutamate-lowering activity in naive rats. Neurochem Res 2012; 37: 2198-2205
25. Ruban A, Berkutzki T, Cooper I, Mohar B, Teichberg VI. Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Invest New Drugs 2012; 30: 2226-2235
26. MacLellan CL, Silasi G, Auriat AM, Colbourne F. Rodent models of intracerebral hemorrhage. Stroke 2010; 41: S95-S98
27. Schaar KL, Brenneman MM, Savitz SI. Functional assessments in the rodent stroke model. Exp Transl Stroke Med 2010; 2: 13
28. Wahl F, Allix M, Plotkine M, Boulu RG. Neurological and behavioral outcomes of focal cerebral ischemia in rats. Stroke 1992; 23: 267-272
29. Balami JS, Buchan AM. Complications of intracerebral haemorrhage. Lancet Neurol 2012; 11: 101-118
30. Ginsberg MD. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 2009; 40: S111-S114
31. Gottlieb M, Wang Y, Teichberg VI. Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem 2003; 87: 119-126
32. Khanna S, Briggs Z, Rink C. Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke. Antioxid Redox Signal 2014; 22: 175-186
33. Li Y, Hou X, Qi Q, Wang L, Luo L, Yang S, et al. Scavenging of blood glutamate for enhancing brain-To-blood glutamate efflux. Mol Med Rep 2014; 9: 305-310
34. Gaberel T, Macrez R, Gauberti M, Montagne A, Hebert M, Petersen KU, et al. Immunotherapy blocking the tissue plasminogen activator-dependent activation of n-methyl-d-Aspartate glutamate receptors improves hemorrhagic stroke outcome. Neuropharmacology 2013; 67: 267-271
35. Campos F, Sobrino T, Vieites-Prado A, Perez-Mato M, Rodriguez-Yañez M, Blanco M, et al. Hyperthermia in human ischemic and hemorrhagic stroke: similar outcome, different mechanisms. PLoS ONE 2013; 8: e78429
36. Wu G, Li C, Wang L, Mao Y, Hong Z. Minimally invasive procedures for evacuation of intracerebral hemorrhage reduces perihematomal glutamate content, bloodbrain barrier permeability and brain edema in rabbits. Neurocrit Care 2011; 14: 118-126